Cleary Gottlieb Steen & Hamilton represented Innocap Investment Management in the transaction. Innocap Investment Management Inc. (“Innocap”), announced that it is acquiring BNY Mellon’s HedgeMark business to...
Innocap’s Acquisition of BNY Mellon’s HedgeMark Business
Electra Therapeutics’ $84 Million Series B Financing
Gunderson Dettmer Stough Villeneuve Franklin & Hachigian advised Electra Therapeutics on the deal. Electra Therapeutics, a clinical-stage biotechnology company, announced its $84 million Series B financing co-led...
Federal Trade Commission v. Altria’s Investment in Juul Labs
Cleary Gottlieb Steen & Hamilton represented Juul Labs in the Federal Trade Commission’s (FTC) lawsuit challenging Altria Group’s $12.8 billion investment in JLI. On February 15,...
Celanese’s Acquisition of Majority of Mobility & Materials Segment from DuPont
Skadden, Arps, Slate, Meagher & Flom and CMS represented DuPont in the transaction, while Kirkland & Ellis, Baker McKenzie and Baker Botts advised Celanese Corporation. DuPont has...
Dover School District’s School Bonds Issuance
Wilentz, Goldman & Spitzer acted as bond counsel to the Board of Education of the Town of Dover. The Board of Education of the Town of...
Spotter’s $200 Million Series D Financing
Latham & Watkins represented SoftBank Vision Fund 2 in the transaction. Spotter, the creator platform, announced US$200 million in Series D financing at a valuation of US$1.7...
Mainsail Partners’ Acquisition of Majority Stake in ServiceCore
Willkie advised Full In Partners in its sale of ServiceCore while Holland & Hart represented ServiceCore. Full In Partners announced the sale of its stake in...
Madison Dearborn Partners’ $1.8 Billion Acquisition of MoneyGram
Latham & Watkins LLP represented MDP in the transaction on the deal while Vinson & Elkins advised MoneyGram International. MoneyGram International, Inc. (NASDAQ: MGI) (the “Company”),...
Sunshine Biopharma’s $8 Million Common Stock Offering
Sichenzia Ross Ference represented Sunshine Biopharma in the offering. Sunshine Biopharma, Inc. finalized an underwritten public offering. The offering consisted of 1,882,353 units at a price to the...
Humu’s $60 Million Series C Funding
Wilson Sonsini Goodrich & Rosati advised Humu on the deal. Humu, an HR company combining behavioral science and technology to help employees build better habits at...
Blue Star Helium Limited’s OTCQB Listing
Sichenzia Ross Ference advised Blue Star Helium Limited on the deal. Blue Star Helium Limited (OTCQB: “BSNLF”), an Australian helium exploration and development company, announced its listing...
Cellino’s $80 Million Series A Financing
Wilson Sonsini Goodrich & Rosati advised Cellino on the deal. Cellino Biotech, an autonomous cell therapy manufacturing company, announced the completion of a Series A financing...